Phillip Gross
@Adage Capital Partners Gp, L.l.c.
Latest period2024 - Q3ReportedManaged Assets$56.635BTotal holdings864
Assets growth rate4.87%Assets growth rate (2-Q avg)3.41%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Adage Capital Partners Gp, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 864 positions.
Assets under management
The assets under management (AUM) of Adage Capital Partners Gp, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 56.635B in assets, with a quarterly growth rate of 4.87% and a 2-quarter average growth rate of 3.41%. The portfolio is managed by Phillip Gross, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
APHAmphenol Corp New
| 0.17% | $92.704M 1.423M shares@ $65.16 avg price | Increased 44.85% |
CBRECbre Group Inc
| 0.17% | $91.978M 738,900 shares@ $124.48 avg price | Increased 13.8% |
ARGXArgenx Se
| 0.17% | $91.496M 168,787 shares@ $542.09 avg price | Increased 58.48% |
PLDPrologis Inc.
| 0.16% | $90.404M 715,900 shares@ $126.28 avg price | Increased 8.44% |
SOCSable Offshore Corp
| 0.16% | $88.069M 3.727M shares@ $23.63 avg price | Increased 1.63% |
HONHoneywell Intl Inc
| 0.16% | $86.671M 419,287 shares@ $206.72 avg price | Increased 0.21% |
RAREUltragenyx Pharmaceutical In
| 0.15% | $84.755M 1.526M shares@ $55.56 avg price | Increased 35.63% |
LENLennar Corp
| 0.15% | $84.332M 449,817 shares@ $187.48 avg price | Increased 16.87% |
METMetlife Inc
| 0.15% | $82.853M 1.005M shares@ $82.48 avg price | Increased 215.87% |
XENEXenon Pharmaceuticals Inc
| 0.15% | $82.046M 2.084M shares@ $39.38 avg price | Increased 13.29% |